Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...

Biologically, how the GLP-1 is delivered into the body should make little difference: It’s the same peptide, just in a ...

This makes Pfizer a potentially cheap stock to buy while collecting a solid dividend. It's generated about $14 billion in ...

As part of the new schedule, HHS will no longer broadly recommend influenza, COVID-19, rotavirus, and other previously ...

Next-generation biologics, such as bispecifics, fusion proteins, and multi-specifics, have multiple functionalities that ...

Biopharma enters 2026 amid continuing scientific progress and accelerating deal activity, yet its business model is under pressure across every facet of the value chain. Investors are taking note: ...

Drs. Gulden Menderes and Levent Mutlu, gynecological oncologists with Health First Medical Group, stress to women to speak up.

The conglomerate received the top environmental, social, and governance honour from the television broadcaster.

In November 2024, what began as a routine seniors' baseball tournament at the Lee Health Sports Complex turned into a life-or-death emergency, and ultimately, a powerful demonstration of Lee County's ...

Consider five potentially undervalued stocks for 2026, including Intel, Ford, Vodafone, Pfizer and Bank of America. Learn ...

The 3rd Next-Generation Conjugates Summit (Boston | February 26-28, 2024) is the only event dedicated to showcasing conjugate drugs with novel payloads and formats, providing unrivalled access to 30+ ...